Volume 12, Issue 3 (11-1998)                   Med J Islam Repub Iran 1998 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
DERAKHSHAN DEILAMI G, GHOLAMHOSSEINI A, POURGHOLAMI M. COMPARISON OF THE BRONCHODIL ATORY EFFECTS OF INHALED SALBUTAMOLAND COMBIVEN T IN ASTHMATIC PATIENTS. Med J Islam Repub Iran 1998; 12 (3) :205-209
URL: http://mjiri.iums.ac.ir/article-1-995-en.html
COMPARISON OF THE BRONCHODIL ATORY EFFECTS OF INHALED SALBUTAMOLAND COMBIVEN T IN ASTHMATIC PATIENTS
G DERAKHSHAN DEILAMI , A GHOLAMHOSSEINI , MH POURGHOLAMI
From the Division of Pulmonology, Imam Khomeini Hospital, Tehran University of Medical Sciences,
Abstract:   (5939 Views)
A randomized, double-blind, crossover trial was designed to compare the acute effects of Combivent and salbutamol on spirometric parameters in patients with moderate to severe asthma. Nineteen patients with a mean baseline forced expiratory volume in 1 sec. (FEV]) less than 65% predicted, were randomized on two separate days to receive two puffs of salbutamol (200 µg) or two puffs of Combivent (200 µg salbutamol plus 40 µg of ipratropium bromide) by metered dose inhalers. On study days using spirometry, FEV!, forced vital capacity (FVC), maximal mid-expiratory flow rate (MMEF) and peak: expiratory flow rates (PEFR) were measured at baseline and at 15, 60 and 180 minutes after drug administration. Blood pressure and pulse rate were also determined before and 3 hours post drug inhalation. The results of this study show that Combivent produces significantly greater improvement compared to salbutamol in all four spirometric parameters at 15, 60, and 180 minutes after drug treatment. The greatest differences between the bronchodilating effects of the two re!imens were observed at 180 minutes after drug inhalation. There were no clinically significant changes in heart rate or blood pressure. It may therefore be concluded that in patients with moderate to severe asthma, Combivent provides better bronchodilation than salbutamo1 alone at clinically relevant doses without increasing side-effects
Keywords: Asthma, bronchodilator, Combivent, ipratropium, salbutamol.
Full-Text [PDF 435 kb]   (2639 Downloads)    
Type of Study: Original Research | Subject: Pharmacology
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.